Reduce Risk, Cost and Time in the New Era of Small Molecule Drug Discovery

Presented by

Hayden Boehm

About this talk

With the renaissance of Small Molecule Drug Discovery, the race to explore uncharted biologically active chemical space is on. However, the process of discovery has multiple challenges that have an impact on time, cost and risk to any Biotech working towards a therapeutic breakthrough. Discover the challenges and how to remove avoidable risks, costs and time to accelerate your path to discovery.
Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (4)
Subscribers (248)
Dotmatics has created the world’s most comprehensive digital science platform – best-of-breed software applications already used by more than 2 million scientists, together in a single ecosystem united by a powerful, flexible enterprise data platform. More than 2 million scientists and 10,000 customers trust Dotmatics to help them create a healthier, cleaner, safer world. This channel will contain insights gained by supporting these scientists in their efforts to fuel discovery.